Humalog® Mix50™ before carbohydrate-rich meals in type 2 diabetes mellitus

Diabetes, Obesity and Metabolism

Volumn 5, Issue 5, 2003, Pages 311-316

  Roach, Paris ^a   Arora, V ^b   Campaigne, B N ^b   Mattoo, V ^g   Rangwala, S ^g   Kumar, Prasanna ^c   Rais, Nadeem ^d   Ramachandran, A ^e   Sridhar, C B ^f  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c M S RAMAIAH MEDICAL COLLEGE   (India)

^d Chowpaty Medical Centre   (India)

^e Diabetes Research Centre Tamil Nadu   (India)

^f ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^g NONE

Author keywords

High carbohydrate; Insulin lispro mixtures

Indexed keywords

CARBOHYDRATE; GLUCOSE; HEMOGLOBIN A1C; HUMALOG MIX25; HUMALOG MIX50; INSULIN LISPRO; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ARTICLE; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG USE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPOGLYCEMIA; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SYMPTOM; TEST MEAL; TREATMENT OUTCOME; AGED; BLOOD; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED;

ADULT; AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 0141540453     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2003.00277.x     Document Type: Article

References (28)

1. Edelman SV, Henry RR. Insulin therapy for normalizing glycosylated hemoglobin in type II diabetes. Diabetes Rev 1995; 3: 308-334.
2. Turner HE, Matthews DR. The use of fixed-mixture insulins in clinical practice. Eur J Clin Pharmacol 2000; 56: 19-25.
3. Bell DSH, Clements RS, Perentesis G, Roddam R, Wagenknecht L. Dosage accuracy of self-mixed vs premixed insulin. Arch Intern Med 1991; 151: 2265-2269.
4. Coscelli C, Calabrese G, Fedele D et al. Use of premixed insulin among the elderly: reduction of errors in patient preparation of mixtures. Diabetes Care 1992; 15: 1628-1630.
5. Anderson JH Jr, Brunelle RL, Koivisto VA et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 1997; 46: 265-270.
6. Anderson JH Jr, Brunelle RL, Keohane P et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157: 1249-1255.
7. Dimitriadis GD, Gerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 1983; 6: 374-377.
8. Roach P, Woodworth JR. Clinical pharmacokinetics and pharmacodynamics of Humalog® Mix25™. Clin Pharmacokinet 2002; 41: 1043-1057.
9. Roach P, Yue L, Arora V. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Diabetes Care 1999; 22: 1258-1261.
10. Roach P, Trautmann M, Arora V, Sun B, Anderson JH Jr. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, Insulin Lispro Mix25 and Insulin Lispro Mix50. Clin Ther 1999; 21: 523-534.
11. The WHO Classification of Diabetes. In: Pickup JC, Williams G eds. Textbook of Diabetes, Vol. 1. Oxford, UK: Blackwell Scientific Publications, 1991; 39.
12. Koch GG. The use of non-parametric methods in statistical analysis of the two period change-over design. Biometrics 1972; 28: 577-584.
13. Taulbee JD. A note on the use of nonparametric methods in the statistical analysis of the two-period changeover design. Biometrics 1982; 38: 1053-1055.
14. Grizzle JE. The two-period changeover design and its use in clinical trials. Biometrics 1965; 21: 467-480.
15. Nagelkerke NJD, Hart AAM, Oosting J. The two period binary response crossover trial. Biometrics 1986; 28: 863-869.
16. Nathan DM. Initial Management of Glycemia in Type 2 Diabetes Mellitus. N Engl J Med 2002; 347: 1342-1349.
17. Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968-983.
18. Ceriello A. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med 1998; 15: 188-193.
19. Ceriello A, Giacomello R, Stel G et al. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 1995; 44: 924-928.
20. Ceriello A, Toboga C, Tonutti L et al. Post-meal coagulation activation in diabetes mellitus: the effect of Acarbose. Diabetologia 1996; 39: 469-473.
21. Beisswenger PJ, Howell SK, O'Dell RM, Wood ME, Touchette AD, Szwergold BS. α-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 2001; 24: 726-732.
22. Rodriguez BL, Lau N, Burchfiel CM et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality. Diabetes Care 1999; 22: 1262-1265.
23. Haffner SM. The importance of hyperglycemia in the non-fasting state to the development of cardiovascular disease. Endocrine Rev 1998; 19: 583-592.
24. Temelkova-Kurktschiev T, Henkel E, Schaper F et al. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil? Exp Clin Endocrinol Diabetes 2000; 108: 93-99.
25. Hanefeld M, Fischer S, Julius U. Risk factors for myocardial infarction and death in newly detected NIDDM. the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996; 39: 1577-1583.
26. 1c level. Diabetes Care 2000; 23: 1830-1834.
27. Kowalska I, Prokop J, Bachorzewska-Gajewska H et al. Disturbances of glucose metabolism in men referred for coronary arteriography: postload glycemia as a predictor of coronary arteriosclerosis. Diabetes Care 2001; 24: 897-901.
28. American Diabetes Association. Postprandial Blood Glucose. Diabetes Care 2001; 24: 775-778.